raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:213

Cystinosis

Synonyms: Protein defect of cystin transport

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

A rare lysosomal disease characterized by an accumulation of cystine inside the lysosomes, causing damage in different organs and tissues, particularly in the kidneys and eyes. Three clinical forms have been described: nephropathic infantile, nephropathic juvenile and ocular.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCystinosisProtein defect of cystin transport
frCystinoseDéficit en transporteur de la cystine
deCystinoseZystinose
esCistinosisDeficiencia de transportador de cistina
itCistinosiDeficit del trasportatore della cistina
nlCystinoseEiwitdefect van cystinetransport
ptCistinoseDefeito proteico no transporte de cistina
plCystynozaBiałkowy defekt transportu cystyny
csCystinózaPorucha transportu cystinu způsobená poruchou membránového proteinu
ukЦистинозДефект білка транспорту цистину
zh胱氨酸贮积症胱氨酸转运蛋白缺陷症
trSistinozSistin taşınmasının protein defekti

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM219800BTNTvalidated
OMIM219900BTNTvalidated
ICD-10E72.0NTBTinclusionvalidated
ICD-115C60.1Especificvalidated
MONDO0016239Evalidated
MeSHD003554Evalidated
UMLSC4316899Evalidated
GARD6236Evalidated
MedDRA10011777Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (3):

4

Genes

0 direct · 3 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CTNSORPHA:411629Infantile nephropathic cystinosisDisease-causing germline mutation(s) inAssessedHGNC:2518ENSG0000004053160627217p13.2cystinosin, lysosomal cystine transporter20301574[PMID]
CTNSORPHA:411634Juvenile nephropathic cystinosisDisease-causing germline mutation(s) inAssessedHGNC:2518ENSG0000004053160627217p13.2cystinosin, lysosomal cystine transporter20301574[PMID]
CTNSORPHA:411641Ocular cystinosisDisease-causing germline mutation(s) inAssessedHGNC:2518ENSG0000004053160627217p13.2cystinosin, lysosomal cystine transporter20301574[PMID]
5

Prevalence and incidence

10 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 1 000 0000.75 / 100 000WorldwideValue and classValidated12110740[PMID]_18008091[PMID]_11562417[PMID]
Prevalence at birth1-9 / 1 000 0000.5 / 100 000EuropeValue and classValidated[EXPERT]
Prevalence at birth1-9 / 1 000 0000.31 / 100 000FranceValue and classValidated1018302[PMID]
Prevalence at birth1-9 / 1 000 0000.59 / 100 000GermanyValue and classValidated3921756[PMID]
Prevalence at birth1-9 / 100 0002.1 / 100 000United KingdomValue and classValidated9610798[PMID]
Prevalence at birth1-9 / 1 000 0000.52 / 100 000AustraliaValue and classValidated9918480[PMID]
Prevalence at birth1-9 / 100 0001.6 / 100 000Specific populationValue and classValidated1937486[PMID]_25274184[PMID]
Point prevalence1-9 / 100 0001.5 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2014[OTHER]
Prevalence at birth1-9 / 1 000 0000.87 / 100 000DenmarkValue and classValidated975942[PMID]_27102039[PMID]
Prevalence at birth1-9 / 1 000 0000.38 / 100 000SwedenValue and classValidated25274184[PMID]_27102039[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

56 annotations · validated 2024-07-17
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003355Aminoaciduria
HP:0007957Corneal opacity
HP:0001944Dehydration
HP:0000823Delayed puberty
HP:0001508Failure to thrive
HP:0012378Fatigue
HP:0002900Hypokalemia
HP:0002148Hypophosphatemia
HP:0000821Hypothyroidism
HP:0001324Muscle weakness
HP:0003198Myopathy
HP:0009806Nephrogenic diabetes insipidus
HP:0000112Nephropathy
HP:0000613Photophobia
HP:0001959Polydipsia
HP:0000093Proteinuria
HP:0001994Renal Fanconi syndrome
HP:0000124Renal tubular dysfunction
HP:0004322Short stature
HP:0100651Type I diabetes mellitus
HP:0002013Vomiting
Frequent (79-30%)
HP:0012072Aciduria
HP:0000585Band keratopathy
HP:0003458EMG: myopathic abnormalities
HP:0003155Elevated circulating alkaline phosphatase concentration
HP:0011968Feeding difficulties
HP:0003076Glycosuria
HP:0001510Growth delay
HP:0002240Hepatomegaly
HP:0003109Hyperphosphaturia
HP:0002901Hypocalcemia
HP:0000135Hypogonadism
HP:0000121Nephrocalcinosis
HP:0000787Nephrolithiasis
HP:0002749Osteomalacia
HP:0000083Renal insufficiency
HP:0000488Retinopathy
HP:0002748Rickets
HP:0001744Splenomegaly
Occasional (29-5%)
HP:0012093Abnormality of endocrine pancreas physiology
HP:0002381Aphasia
HP:0000027Azoospermia
HP:0002019Constipation
HP:0006824Cranial nerve paralysis
HP:0003234Decreased circulating carnitine concentration
HP:0001738Exocrine pancreatic insufficiency
HP:0001945Fever
HP:0001288Gait disturbance
HP:0001952Glucose intolerance
HP:0002902Hyponatremia
HP:0001252Hypotonia
HP:0001256Intellectual disability, mild
HP:0002024Malabsorption
HP:0001942Metabolic acidosis
HP:0001409Portal hypertension
HP:0000505Visual impairment

Run the differential on the 12 obligate / very frequent terms

Annotation source: 27102039[PMID]_20301574[PMID]

7

Sources for this card